Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Christopher A. Bravery"'
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 18, Iss , Pp 269-279 (2020)
Advanced therapy medicinal products (ATMPs) comprising cell therapy, gene therapy, and tissue-engineered products, offer a multitude of novel therapeutic approaches to a wide range of severe and debilitating diseases. To date, several advanced therap
Externí odkaz:
https://doaj.org/article/d3dd08c6372448228f76cd959e363888
Autor:
Christopher A Bravery
Publikováno v:
Cell and Gene Therapy Insights. :1697-1704
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4429629c6095b26f9e494cd248a4eaa6
https://doi.org/10.18609/cgti.2021.224
https://doi.org/10.18609/cgti.2021.224
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 18, Iss, Pp 269-279 (2020)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy. Methods & Clinical Development
Advanced therapy medicinal products (ATMPs) comprising cell therapy, gene therapy, and tissue-engineered products, offer a multitude of novel therapeutic approaches to a wide range of severe and debilitating diseases. To date, several advanced therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32bd9b64c1546a2b6e65194ce22261cd
http://www.sciencedirect.com/science/article/pii/S2329050120301224
http://www.sciencedirect.com/science/article/pii/S2329050120301224
Publikováno v:
Cell and Gene Therapy Insights. 5:759-791
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c49dc8e0b08628fc3f379dbf1406917
https://doi.org/10.18609/cgti.2019.088
https://doi.org/10.18609/cgti.2019.088
Publikováno v:
Cell and Gene Therapy Insights. 4:207-225
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e9b57c246654202914c596b7470ada7
https://doi.org/10.18609/cgti.2018.022
https://doi.org/10.18609/cgti.2018.022
Publikováno v:
Pharmaceutical Research, 36(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::220090f4e55c68ba91791aedbb1b3d2b
http://hdl.handle.net/1887/120041
http://hdl.handle.net/1887/120041
Autor:
Kentaro Yoshimatsu, Pierrette Zorzi-Morre, Mahendra Rao, Takao Hayakawa, Takashi Aoi, Akifumi Matsuyama, Akihiro Umezawa, Kazuo Yano, Masayuki Yamato, James W. McBlane, Norihisa Sakamoto, Jean-Hugues Trouvin, John Petricciani, Hiroyuki Yokote, Ivana Knezevic, Junichi Koga, Anthony Ridgway, Daisaku Sato, Yoji Sato, Karin H. Hoogendoorn, Tomohiro Morio, Glyn Stacey, Christopher A. Bravery, Daisuke Maeda
Publikováno v:
Biologicals. 43:283-297
The regulation of human cell therapy products is a key factor in their development and use to treat human diseases. In that regard, there is a recognized need for a global effort to develop a set of common principles that may serve to facilitate a co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c13f80ba9fca641039d6c20742054e1
https://doi.org/10.1016/j.biologicals.2015.07.009
https://doi.org/10.1016/j.biologicals.2015.07.009
Autor:
Amit Chandra, Mahendra S. Rao, Hae-Won Kim, Doug Sipp, Glyn Stacey, Guillermo García-Cardeña, Joseph C. Wu, Alexander Meissner, Jonathan C. Knowles, Natalie Artzi, Joseph D. Gold, Andrew Carr, David Brindley, Ivan B. Wall, Christopher A. Bravery, David J. Williams, Peter R.T. Archibald, Richard W. Barker, James R. Smith, Kim Bure, Anna French, Jeanne F. Loring, Brock Reeve, Evan Y. Snyder, Jeffrey M. Karp, Steve Oh
Publikováno v:
Stem Cells Translational Medicine. 4:217-223
Summary There is a need for physical standards (reference materials) to ensure both reproducibility and consistency in the production of somatic cell types from human pluripotent stem cell (hPSC) sources. We have outlined the need for reference mater
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::679d39e9e846654a7919a40245c3a73e
https://doi.org/10.5966/sctm.2014-0233
https://doi.org/10.5966/sctm.2014-0233
Autor:
Anna French, Christopher A. Bravery
Publikováno v:
Cytotherapy. 16:1187-1196
The development of cellular therapeutics (CTP) takes place over many years, and, where successful, the developer will anticipate the product to be in clinical use for decades. Successful demonstration of manufacturing and quality consistency is depen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e009a0e5e1922f2ffd786dccd279986
https://doi.org/10.1016/j.jcyt.2014.05.024
https://doi.org/10.1016/j.jcyt.2014.05.024
Autor:
M May, I Bingham, Christopher A. Bravery, M S Rattley, Amit Chandra, Andrew Judge, Andrew Carr, Ivan B. Wall, Gilles Lemaitre, E Titus, B Siegel, Benjamin Davies, K Rooke, Y. Laabi, Richard W. Barker, A Kramm, Anna French, M Morys, Rafael Pinedo-Villanueva, R L Buckler, David J. Williams, Liam M. Grover, Rob Horne, Douglas Sipp, Mark E. Morrey, David Brindley, Brock Reeve, Afsie Sabokbar, Mackenna Roberts, R Zahkia, Evan Y. Snyder, Jeffrey M. Karp, J Suh, K Krumholz, Hannah Hurley, Sarah Rikabi, D McKeon, Karolina Wartolowska, R Pigott, L Hook, Kim Bure
Publikováno v:
Stem Cells and Development. 22:63-72
Increased global connectivity has catalyzed technological development in almost all industries, in part through the facilitation of novel collaborative structures. Notably, open innovation and crowd-sourcing-of expertise and/or funding-has tremendous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::119bcb03c2921c15b0015ecc0e3e3b43
https://doi.org/10.1089/scd.2013.0403
https://doi.org/10.1089/scd.2013.0403